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Abstract 
Diabetes is a growing global problem and a heavy financial burden on health care services. It 
is estimated that over 380 million people suffer from this condition which causes many 
deaths each year in addition to being associated with increased risk of other health problems. 
Traditional medicine is a promising area of research in diabetes therapy as it is widely 
accessible and it is believed that over 200 plants have anti-diabetic properties including 
members of the cucurbit family. Studies in animal and human models have shown that 
treatment with some cucurbits has hypoglycaemic effects and stimulates beta cell 
regeneration in addition to other anti-diabetic effects which are equal to that of commonly 
prescribed anti-diabetic drugs. It has also been shown that at least one of the bioactive 
components which stimulate these effects is a polysaccharide. 
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1. Introduction 
Traditional medicine is the only medicine available to 75 % of the planet’s population 
(Yamada, 2008) and is therefore of significant interest and carbohydrates and 
glycoconjugates are important in disease related applications (Rudd and Dwek, 2006).  Plants 
are often used in traditional medicine with over 200 species thought to be beneficial in the 
treatment of diabetes (Jia, Gao and Tang, 2003), many of these traditional medicines are 
thought to have active polysaccharide components (Fu, Shi and Li, 2006). 
 
The Curcurbiteae family, also referred to as cucurbits (Figure 1), are a group of fruit 
producing plants (Weng and Sun, 2012). They form a very large group with approximately 
130 genera and 800 species and can be cultivated worldwide (Dhiman, Gupta, Sharma, Gill 
and Goyal, 2012) and make popular food crop plants (Behera, Sureja, Islam, Munshi and 
Sidhu, 2012) some of these species include pumpkins, squashes, gourds and melons (Huang, 
Tan, Tan and Peng, 2011; Noelia, Roberto, de Jesus and Alberto, 2011; Song, Zhang, Zhou, 
Zhang, Hu and Li, 2012; Weng and Sun, 2012).  
 
 
Figure 1 Seen on this image is a selection of cucurbits of the South Korean Genebank in 
Suwon (2010). Including luffas (Luffa aegyptiaca), wax gourds (Benincasa hispida), bottle 
gourds (Lagenaria siceraria), snake gourds (Trichosanthes cucumerina), pumpkins, gourds 
and squash (Cucurbita sp.). Reproduced with kind permission from Crops for the Future 
(http://www.cropsforthefuture.org/). 
 
Cucurbits are of interest because of the extensive range of medicinal properties they have 
been reported to exhibit (Dhiman, et. al. 2012). Traditional medicine, particularly the Chinese 
(Fu, et al., 2006) and Ayurvedic systems (Chaturvedi, 2012), have made use of various parts 
of cucurbit plants; including the seeds and flesh of the fruits they produce (Dhiman, et. al. 
2012). There are reports of traditional medicinal polysaccharides exhibiting a number of 
important physiological properties including: tumour growth inhibition, wound healing, 
immunomodulating and hypoglycaemic effects (Fu, et al., 2006; Inngjerdingen, et. al., 2007; 
Košťálova, Hromádková, Ebringerová, Polovka, Michaelsen and Paulsen, 2013).  
 
It is believed that over 200 plants have blood glucose lowering properties, including many 
common plants such as those belonging to the cucurbit family (Jia, et. al., 2003) of which the 
active ingredient of several has been shown to be a polysaccharide such as that found in 
pumpkin (Fu, et al., 2006). Yet currently plant polysaccharides as medicines are under 
researched. Polysaccharides can be difficult to characterise due to their natural variability in 
terms of composition, structure, molecular weight and conformation. The polysaccharides 
found in the fruit of a plant may differ due to many factors including the fruit development 
(Li, Fan, Yang and Shen, 2006), ripeness of the fruit and the environment in which the plant 
was grown (Dong, Cui, Song, Zhao, Ji, Lo and Tsim, 2003). Polysaccharides are less 
researched than other bioactive molecules such as proteins because they are more difficult to 
work with, they are more difficult to obtain as they are not coded for directly, they are also 
relatively easy to break down in digestion so delivery mechanisms would need to be looked 
at more carefully (Duus, Gotfredsen and Bock, 2000).  
 
It is known that, like proteins, polysaccharides are capable of interacting with an organism 
causing a change in biological activity (Yang and Zhang, 2009). The interaction and effect of 
the interaction varies greatly due to the conformation (Yang and Zhang, 2009) and other 
potential interactions of the polysaccharide (Patel, et al., 2007; Heinze, et. al., 2011). 
Polysaccharides are known to be able to modulate the immune system through the 
stimulation of macrophages (Schepetkin and Quinn, 2006) have anti-tumour effects (Wasser, 
2002), reduce inflammation (Wu, Duan, Liu and Cen, 2010) and as a hypoglycaemic agent 
(Xiong and Cao, 2001; Zhang and Yao, 2002; Cai, Yan and Li, 2003). Polysaccharides from 
food plants such as the cucurbiteae family may make very good medicines as they are often 
eaten in the diet and are therefore unlikely to be harmful to the patient (Wang, Zhang and 
Dong, 2012).  
Glucose is the source of energy used by the brain so it is essential that there is always glucose 
in supply in the body, including in times of fasting (Rang, Dale, Ritter and Flower, 2007). 
More energy is available in the food we eat than is needed in one burst so in healthy 
individuals the excess is stored as glycogen or fat (Rang, et al., 2007). The most important 
hormone in the regulation of how much is stored and how much is used is insulin. The greater 
the level of insulin the greater the amount of glucose is stored. However when blood sugar 
levels drop the insulin produced is reduced and there is an increase in the production of other 
hormones including glucagon, adrenaline, glucocorticoids and growth hormone which 
increase the levels of blood sugar through conversion of stored energy back to glucose (Rang, 
et. al., 2007). 
 
Diabetes mellitus is a fairly common condition arising from defects in production or action of 
insulin which causes hyperglycaemia (Nelson, Lehninger and Cox, 2008).  Non-diabetic 
humans have a blood sugar level of between 4 and 7 mmol/L however non-controlled 
diabetic patients have a much higher concentration of glucose in their blood. If left untreated 
many complications can arise, which may even lead to death (Yadav, Morris, Harding, Ang 
and Adams, 2009). 
 
The high prevalence of diabetes and other health issues associated with this disease is a 
financial burden on already stretched health care services. A study of health problems with 
U.S. patients with diabetes showed that sufferers are more likely to suffer from fair or poor 
health than non-sufferers (Gregg, et. al, 2000). These health problems include heart 
problems, kidney disease, impaired vision, limb loss and general poor health than non-
diabetic patients in addition to needing on-going health checks and, in many cases, insulin 
(Yadav, et. al., 2009). Diabetes influences the quality of life of the patients as well as forcing 
them to undergo lifestyle changes such as regular monitoring of their blood glucose levels 
(Smyth and Heron, 2006). It is estimated that over 380 million people suffer from this 
condition (Figure 2) and is the cause of more than 2.9 million deaths each year (Yadav, et. 
al., 2009) with these figures projected to rise over the next 30 years. The majority of people 
suffering from diabetes are aged between 45 and 64 therefore are not elderly and so the care 
they will require is likely to be needed for many years (Cockram, 2000; Wild, Roglic, Green, 
Sicree and King, 2004). 
 
There are two classes of diabetes mellitus known as Type 1 Diabetes mellitus (T1DM) and 
Type 2 diabetes mellitus (T2DM). T1DM is much less common with only 5 - 10 % of all 
diabetes cases being type 1 (Inzucchi, 2004). This type of diabetes usually presents itself 
early in life though can occur at any age with some cases not being seen until the patient is 
elderly (Adams, et. al, 2011). It is caused by damage to beta cells, which produce insulin, due 
to an auto-immune reaction. This damage causes greatly reduced or absent insulin production 
(Serreze, Flemming, Chapman, Richard, Leiter and Tisch, 1998), as a result patients with 
type 1 diabetes have to inject themselves with insulin to modulate their blood glucose levels 
(Atkinson and Eisenbarth, 2001). T2DM is also known as non-insulin dependent diabetes 
mellitus (Nelson, et. al., 2008). The majority of cases of diabetes are type 2 (Raslova, 2010). 
Typically type 2 diabetes is slow to develop with symptoms often initially going un-noticed 
for many years; it is frequently associated with older, obese patients. Unlike patients with 
type one diabetes, T2DM patients do not always have a problem with the production of 
insulin and sometimes they produce more insulin than should be needed however faults in 
their insulin-response system cause them to have reduced or total lack of insulin action, these 
individuals are referred to as being insulin-resistant (Nelson, et.al. , 2008). 
 
 
Figure 2 World map showing the prevalence estimation of diabetes by region in 2013. Data 
reproduced with kind permission from the Diabetes Atlas, sixth edition ©International 
Diabetes Federation, 2013. 
 
Over many years research has been carried out to develop alternative novel drug delivery 
systems that would mimic the physiological environment by delivering insulin, in response to 
the blood glucose level.  Formulations such as hydrogels, microcapsules, liposomes, and 
other soft technology systems as well as inserts and nanoparticles have been proposed 
(Taylor, Tanna, Taylor and Adams, 1995; Le Bourlais, Acar, Zia, Sado, Needham and 
Leverge, 1998; Gupta, Madan, Majumdar, and Maitra, 2000; Willoughby, Batterbury, and 
Kaye, 2002; Yadav, et. al., 2009; Adams, et. al., 2011) but no universal remedy for the 
problems of protein/hormonal delivery have been developed and clinically proven.  
Consequently, patients continue to be treated by regular injections of insulin via the 
traditional subcutaneous route.  Under these conditions, the glucose level of the patient is 
monitored externally and when hyperglycaemia occurs insulin is administered 
subcutaneously. This type of treatment is difficult and tedious and has led to lack of 
adherence to insulin regimens.  As a result, there is increased interest in alternative/ 
traditional therapies based on, for example, polysaccharides. 
 
The focus of this article is to highlight some of the recent examples of the characterisation 
and utilisation of cucurbit polysaccharides in diabetes management. 
 
2. The potential role of cucurbit polysaccharides in diabetes management 
Cucurbita moshata , also known as butternut squash has been used as a traditional medicine 
and health food in China for many years, as it is believed to be beneficial to the spleen and 
lungs (Li, Fu, Rui, Hu and Cai, 2005; Jiang and Du, 2011) in addition to having more specific 
therapeutic properties including anti-inflammatory, anti-tumour, cholesterol lowering, 
hypertensive, anti-parasitic and anti-diabetic effects (Fu, et al., 2006; Dabaghian, 
Kamalinejad, Shojaei and Fard, 2012) 
 
Momordica charantia  is known by several different names including: karela, bitter gourd, 
bitter melon, balsam pear, bitter apple, African cucumber and wild cucumber (Krawinkel and 
Keding, 2006). It is grown in India, China, Eastern Africa and South America and is used in 
many of these countries to treat a variety of ailments. It is important to note the stage of 
development of the fruit and therefore the physic-chemical properties of the polysaccharide 
are important in the bioactive potential for example the unripe fruit of the bitter gourd is 
eaten as a treatment for diabetes and scientific testing has demonstrated that it does exhibit 
blood glucose concentration lowering properties in both human and animal models (Kumar, 
Vijayalakshmi and Salimath, 2006; Nkambo, Anyama and Onegi, 2013; Palamthodi and 
Lele, 2014). It has been shown that water extracts from bitter gourd increase the uptake of 
glucose and secretion of adiponectin from fat cells (Dhiman, et. al., 2012). Adiponectin is a 
protein which can be secreted from adipose cells, low plasma levels of adiponectin are 
associated with insulin resistance and levels of this hormone are seen to be significantly 
lower in patients with type 2 diabetes (Chandran, Philips, Ciaraldi and Henry, 2003). Some of 
the molecules from bitter gourd which have anti-diabetic properties include charatin, vicine, 
polypeptide-p and non-specific anti-oxidants (Krawinkel and Keding, 2006).  
 
Pumpkins (Cucurbita moshata duch) are known to contain several bioactive molecules 
including proteins, peptides, polysaccharides, sterols and para-aminobenzoic acid. These 
components can be found in seeds, flesh of the fruit and the leaves (Yadav, Jain, Tomar, 
Prasad and Yadav, 2010; Adams, et. al., 2011; Patel, 2013; Adams, Imran, Wang, 
Mohammad, Kök, Gray, Channell and Harding, 2014). Pumpkin has been shown several 
times to have anti-diabetic properties and the majority of these bioactive chemicals are 
concentrated in the fruit (Behera, et al., 2012). The polysaccharide extracted from Cucurbita 
moshata (PP1-1) caused a significant, non-competitive inhibition of α-glucosidase at 
concentrations of 0.7-0.9 mg/ml tested in an enzymatic reaction (Song, et. al., 2012). It has 
also been shown that powdered pumpkin from the species Cucurbita moshata duch has 
hypoglycaemic properties in human type 2 diabetes sufferers (Chen, Wang, Jie, Huang and 
Zhang, 1994) which was shown to be due to polysaccharide components (Xiong and Cao, 
2001; Norfezah, Hardacre and Brennan, 2011). Protein-bound polysaccharides have been 
demonstrated to be capable of lowering blood glucose concentrations, increasing serum 
insulin levels and improving glucose tolerance in rats which have been treated with alloxan 
which destroys their β cells and therefore induces diabetes, it is thought that this effect may 
have been due to the antioxidant nature of the polysaccharide protecting the pancreatic β cells 
(Li, Fu, Yukui, Guanghui and Tongyi, 2005)  
 
A clinical study of 30 T2DM patients were treated with polysaccharide granules from 
pumpkin and compared to a control group, urination and blood tests were monitored and the 
results showed an improvement in the treated patients, this shows that polysaccharides from 
pumpkin are capable of controlling glycaemia (Shi, Xiong, Cao and Kang, 2003).  
Water-extracted pumpkin polysaccharides were shown to possess superior hypoglycaemic 
properties compared to glibenclamide in alloxan-induced diabetic rats (Zhang, 2004). This is 
perhaps partially explained by the fact that pumpkin is rich in pectin, (Fissore, Ponce, Stortz, 
Rojas and Gerschenson, 2007), which when consumed is reported to control glycaemic levels 
and reduce the need for insulin when fibre-rich foods are consumed by patients with diabetes 
(Guillon and Champ, 2000). 
 
Melons have been shown to have anti-diabetic effects (Perkins-Veazie, 2010), as little as 1 % 
supplement with ethanol extract from Citrullus vulgaris (commonly known as watermelon) 
rind has been shown to have a significant lowering effect on blood glucose and raises serum 
insulin concentrations in rats, using immunohistochemistry it was determined that this is due 
to watermelon having a protective effect on the pancreatic β cells (Ahn, Choi, Kim and Ha, 
2011). A high dose of watermelon juice has also been shown to have hypoglycaemic and 
hypolipidemic effects in diabetic rats (El-Razek and Sadeek, 2011).  
 
Other cucurbits which are believed to have anti-diabetic properties include a variety of 
gourds: Cucurbita ficifolia (fig leaf gourd), Trichosanthes cucumerina (snake gourd) and 
Benincasa hispida (wax gourd) (Dhiman, et. al., 2012; Palamthodi and Lele 2014). A variety 
of Cucurbiteae pepo better known as a courgette or zucchini may have anti-diabetic effects 
which are thought to stem, at least partially, from its antioxidant properties (Hamissou, 
Smith, Carter and Triplett, 2013). 
 
The fibrous inside of the mature fruit of sponge gourd (Luffa cylindrica) often known as a 
luffah or a bath sponge is often used as a cleaning sponge, a component of shock absorbers, 
for making filters or as part of the sole of shoes however the immature fruit can be eaten. 
They are believed to be good for diabetes (Bal, Hari, Radha, Madhusudan, Bhuwon and 
Madhusudan, 2004) and ethanol extracts from Luffa aegyptiaca  (another species of sponge 
gourd) leaves have been shown to decrease blood sugar level in alloxan induced diabetic rats 
as much as the popularly used pharmaceutical treatment metformin without having a 
significant effect on healthy control rats (El-Fiky, Abou-Karam and Afify, 1996). 
 
Sharmin et. al. (2012) looked at the hypoglycaemic and hypolipidemic properties of three 
species from the cucurbiteae family: Cucumbis sativus (cucumber), Lagenaria siceraria  
(white pumpkin) and Luffa acutangula  (ridge gourd). Tests were carried out using crude 
ethanol extracts from the fruits of these cucurbits which were given to alloxan induced 
diabetic rats. Results of blood glucose levels, cholesterol levels, triglyceride levels, low 
density lipoprotein levels and improvement in glycolysis from injected doses of 200 mg/kg 
extract were looked at alongside healthy control rats, diabetic rats and diabetic rats injected 
with 150 mg/kg of metformin. Results (Figure 3) show a significant decrease in blood 
glucose in alloxan induced diabetic rats when treated with cucurbit extracts. Hyperglycaemic 
potency is highest in the cucumber followed by the white pumpkin and then the ridge gourd 
though all three had significant anti-hyperglycaemic effects. Cholesterol and  is reported to be 
high in alloxan induced diabetic rats, this study also demonstrated the cholesterol lowering 
action of cucumber extract, white pumpkin extract and ridge gourd extract as can be seen in 
Figure 4 (Sharmin, Khan, Akhtar, Alim, Islam, Anisuzzaman and Ahmed, 2012). 
 
Figure 3 Effects of various cucurbits on the fasting blood glucose levels of alloxan induced 
diabetic rats over time. # indicates a significant increase in blood glucose levels when 
compared to the healthy control and * indicates a significant decrease compared to the heal 
(Sharmin, et. al., 2012). Reproduced with kind permission from Prof. A.K.M. Azharul Islam 
Editor-in-Chief, Journal of Scientific Research. 
 
 
 
 
 
Figure 4 Total cholesterol levels from the serum of alloxan induced diabetic rats compared to 
a healthy control group where # represents significant increase in cholesterol levels compared 
to healthy and * represents a significant decrease in total cholesterol (Sharmin, et. al., 2012). 
Reproduced with kind permission from Prof. A.K.M. Azharul Islam Editor-in-Chief, Journal 
of Scientific Research. 
 
A further study (Zhang, Chen, Zhang, Jin, Li and Yao, 2003) demonstrated similar beneficial 
effects on blood glucose concentration, total cholesterol and triglyceride levels with the oral 
administration of water soluble pectin-like polysaccharide consisting of glucose, galactose, 
arabinose and rhamnose and hexuronic acid extracted from Cucurbita moschata. This 
polysaccharide was tested on alloxan induced diabetic rats and also contained a control drug 
comparison however Xiaoke pills (a Chinese patented drug) were used rather than metformin. 
The study also showed glycosylated haemoglobin and beta cell proliferation in the pancreas 
of alloxan induced diabetic rabbits treated with the polysaccharide from the cucurbit (Zhang, 
et. al., 2013). 
 
Figure 5 shows an electron microscope image of stained cells in the islets of langerhans from 
three groups of rabbits. The control group (A) is healthy rabbit pancreas cells with a clear 
mass of stained beta cells, Group B was from an alloxan induced diabetic rabbit pancreas and 
group C is from alloxan induced diabetic rabbits treated the polysaccharide extracted from 
Cucurbita moshata. The beta cells were stained deep purple-red using orange G-brilliant 
green stain. As can be seen from the images beta cell regeneration is induced by the oral 
administration of the polysaccharide. As yet there is still no mechanism for the anti-diabetic 
effects of the cucurbit polysaccharide (Zhang, et. al., 2013). Similarly beta cell regeneration 
has been reported in streptozotocin induced diabetic rats treated with juice from bitter gourd 
(Ahmed, Adeghate, Sharma, Pallot and Singh, 1998).  
 
Figure 5 Effect of polysaccharide from Cucurbita moschata  on beta cells. Images from an 
electron microscope. A is from a healthy control group, B is from a diabetic control group not 
treated for diabetes and C is from the pancreas of a rabbit treat with injected polysaccharide 
from Cucurbita moschata (Zhang, et. al., 2013). Reproduced with kind permission from 
Elsevier. 
 
The effect of pumpkin on insulin levels and glucose tolerance in diabetic rats was 
investigated. Diabetes was induced with alloxin and various doses of protein bound 
polysaccharide extracted from pumpkin were given orally to rat groups. The results showed 
that the protein bund polysaccharide lowered the blood glucose concentration, increased the 
serum production and improve glucose tolerance (Li, et. al., 2005); this is similar to other 
experiments done with other cucurbits and suggests beta-cell regeneration like that seen with 
bitter gourd. 
 
  
Table 1 The effect of protein bound polysaccharide from pumpkin on blood glucose 
tolerance and serum insulin levels. Group 1 rats were healthy controls (not shown in the 
table). With kind permission from Springer Science+Business Media: Plant Foods for 
Human Nutrition, Effects of protein-bound polysaccharide isolated from pumpkin on insulin 
in diabetic rats, 60, 2005, 13-16, Quanhong, Caili, Yukui, Guanghui and Tongyi, Table 3).  
   
Blood glucose and tolerance at time after treatment 
(mmol/l) 
Group 
Dose 
(mg/ml) 
Insulin 
(uIU/ml) 0 hours 0.5 hours 1 hour 2 hours 
Group 2 0 62.5 ± 21.18 23.65 ± 11.17 27.33 ± 9.82 22.11 ± 10.33 20.14 ± 9.85 
Group 3 1000 100.4 ±33.89 12.64 ± 10.81 19.43 ± 10.90 14.81 ± 9.69 12.03 ± 9.46 
Group 4 500 105.3 ± 6.73 13.23 ± 6.73 21.10 ± 9.76 15.28 ± 9.40 12.79 ± 9.18 
Group 5 20 103.4 ± 38.73 13.84 ± 6.42 23.11 ± 9.27 18.13 ± 9.01 14.00 ± 8.56 
 
Sechium edule, also known as choko, sayote, chow-chow or vegetable pear, is a member of 
the cucurbit family which has been investigated for its anti-diabetic properties on diabetic 
rats. Extract from the fruit was taken through ethanol extraction and distillation. The rats 
were divided into five groups: group 1- healthy controls, group 2- alloxan induced diabetic 
rats, group 3- alloxan induced diabetic rats treated with 5mg/kg of Glibenclamide (an anti-
diabetic drug), group 4- alloxan induced diabetic rats treated with 200 mg/kg of extract from 
Sechium edule and group 5- alloxan induce diabetic rats treated with 100 mg/kg of extract 
from Sechium edule. After 21 days of treatment blood was drawn and tested for serum 
glucose, total cholesterol, serum triglycerides, Low density lipoprotein (LDL)-cholesterol, 
high density lipoprotein (HDL)-cholesterol and very low density lipoprotein (VLDL)-
cholesterol. Total cholesterol levels decreased significantly as did triglycerol levels, LDL-
cholesterol and VLDL-cholesterol when treated with Sechium edule. HDL cholesterol levels 
also increased in diabetic rats treated with the extract from the cucurbit when compared to the 
non-treated diabetic rats. Other observations in this study showed a significant decrease in 
blood glucose levels when treated with the Sechium edule extract compared with non-treated 
diabetic rats and the prevention of weight loss normally seen with diabetes (Maity, Firdous 
and Debnath, 2003).  
 
Table 2 Biological parameters of rats treated with Sechium edule and controls after 21 days. 
With kind permission from World Journal of Pharmacy and Pharmaceutical Sciences, 
Evaluation of antidiabetic activity of ethanolic extract of sechium edule fruits in alloxan-
induced diabetic rats, 2, 2013, 3612-3621, Maity, Firdous and Debnath, Table 2).   
Biochemical 
parameter 
(mg/dl) 
Healthy 
control 
Diabetic 
control 
Diabetic 
treated with 5 
mg/kg 
Glinbenclamide 
Diabetic 
treated with 
200 mg/kg 
Sechium edule 
Diabetic 
treated with 
100 mg/kg 
Sechium edule 
Serum 
cholesterol  
63.72 ± 1.29* 148.9 ± 2.77 71.48 ± 0.61*a 79.04 ± 0.58*b 86.25 ± 0.68*b 
HDL 
Cholesterol 
52.68 ± 0.73* 38.73 ± 2.43 55.34 ± 0.76*a 71.82 ± 0.77*b 62.01 ± 0.47*b 
Serum LDL 
cholesterol 
51.75 ± 1.89* 148.7 ± 2.23 60.27 ± 0.36*a 74.03 ± 3.36*b 121.7 ± 3.86*b 
Serum 
VLDL 
cholesterol 
29.4 ± 1.58* 36.97 ± 0.27 32.53 ± 0.72*a 31.43 ± 0.47*b 35.6 3± 0.43*b 
Serum 
Triglycerides  
147.2 ± 0.54* 242.1 ± 0.76 155.9 ± 2.02*a 165.1 ± 0.54*b 170.5 ± 0.56*b 
 
*p < 0.01 when compared to diabetic control 
ap < 0.01 diabetic rats treated with Glinbenclamide when compared with diabetic control. 
bp < 0.01 diabetic rats treated with Sechium edule when compared with diabetic control. 
 
A study looking at the hypoglycaemic effects of another member of the cucurbiteae family, 
Cucurbita ficifolia Bouché also known as chilacayote, which is used in Mexico as a treatment 
for diabetes showed not only that the juice has an anti-diabetic effect but that it may also be 
toxic (Alarcon-Aguilar, Hernandez-Galicia, Campos-Sepulveda, Xolalpa-Molina, Rivas-
Vilchis, Vazquez-Carillo and Roman-Ramos, 2002). Experiments on healthy mice showed 
that oral and intraperitoneal administrations of freeze dried juice from the fruit of this 
cucurbit showed a dose dependant anti-diabetic effect. In the minutes following 
intraperitoneal administration of 750 to 1250 mg/kg of freeze dried chilacayote juice many 
deaths were observed which suggests that in high doses the juice can be toxic. 14 day oral 
administrations were also investigated and it was found that they significantly reduce blood 
glucose levels in alloxan induced diabetic rats however once again toxicity was also 
observed. Current use in diabetic patients in Mexico are of a much lower dose (100 mg/kg) 
and no toxic effects have been seen suggesting that only high doses are toxic (Alarcon-
Aguilar et. al., 2002). Toxicity effects would need to be further investigated prior to further 
testing and eventual approval.    
 
  
Table 3 A summary of the potential anti-diabetic effect of cucurbit polysaccharides 
Species 
Common 
Name 
Putative Therapeutic Effect Reference 
Citrullus 
vulgaris 
watermelon 
lowers blood glucose; increases serum 
insulin concentrations; protective effect 
on the pancreatic β cells 
Ahn, et. al., 
2011 
Cucurbita 
ficifolia 
Bouché 
chilacayote lowers blood glucose 
Alarcon-
Aguilar, et al., 
2002 
Cucurbita 
moshata duch 
pumpkin 
lowers blood glucose concentrations; 
increases serum insulin levels; beta cell 
regeneration 
Quanhong et. 
al., 2005; 
Zhang, et al., 
2013 
Cucumbis 
sativus 
cucumber lowers blood glucose 
Sharmin, et. al., 
2012 
Lagenaria 
siceraria 
white gourd lowers blood glucose 
Sharmin, et. al., 
2012 
Luffa 
acutangula 
ridge gourd lowers blood glucose 
Sharmin, et. al., 
2012 
Luffa 
aegyptiaca  
sponge gourd lowers blood glucose 
El-Fiky, et. al., 
1996 
Luffa 
cylindrica 
sponge gourd believed to be beneficial in diabetes 
El-Fiky, et. al., 
1996 
Momordica 
charantia 
 
karela, bitter 
gourd, bitter 
melon, balsam 
pear, bitter 
apple, African 
cucumber or  
wild cucumber 
increases the uptake of glucose and 
secretion of adiponectin from fat cells 
Dhiman, et. al., 
2012 
Sechium 
edule 
choko, sayote, 
chow-chow or 
vegetable pear 
lowers blood glucose 
Maity, et. al., 
2013 
3. Conclusions 
Studies have evidently shown that cucurbits are a promising area of research into plant based 
anti-diabetic agents (Table 3). There is significant evidence that fruits of the cucurbit family 
are effective as anti-diabetic treatments however the mode (or modes) of action is as yet 
unknown. The majority of tests have been carried out with crude extracts with only a few 
papers characterising the molecules that are being used. Where polysaccharides have been 
suitably characterised it appears as though pectins (or pectin-like polysaccharides) are a 
suitable candidate as the potentially bioactive polysaccharide (Zhang, et al., 2003; Fissore, et 
al., 2007; Inngjerdingen, et al., 2008; Grønhaug, et al., 2010; Košťálova, Hromádková and 
Ebringerová, 2013; 2014). Further knowledge the fine structure (e.g. sugar composition, 
linkage, molar mass and conformation) of these bioactive polysaccharides (and any natural 
variation in fine structure) could lead to potential routes to modification (Inngjerdingen, et. 
al., 2007; Košťálova, et al., 2013; 2014), synthesis (Flitsch, 2000; Ladmiral, Melia and 
Haddleton, 2004; Vázquez-Dorbatt, Lee, Lin and Maynard, 2012) or fractionation (Morris 
and Ralet, 2012a,b) which may produce more effective carbohydrates for use in the control of 
diabetes or in the supplementation of functional foods (Norfezah, et al., 2011; Morris and 
Morris, 2012). Currently there is no research to suggest whether the biologically active 
component of these plants is the same in each cucurbit through the effects seem to be 
consistent throughout the cucurbit family. It has been shown that the bioactive component in 
Cucurbita moshata  is a polysaccharide (Zhang, et. al., 2013) though further research would 
be required to identify if this is true for all members of this family.  
 
Current lack of knowledge of the structure and toxicity of the bio-active components of 
cucurbits does not sit well with pharmaceutical agencies and would have to be further 
researched in order for it to become a viable option in western medicine (Paterson, 2008) 
once characterised enzymatic (Fissore, et al., 2007; Inngjerdingen, et. al., 2007) or chemical 
modifications (Morris, Ebringerová, Harding, and Hromádková, 1999;  Morris, Hromádková, 
Ebringerová, Malikova, Alfoldi, and Harding, 2002; Koschella, Inngjerdingen, Paulsen, 
Morris, Harding and Heinze, 2008)  could be used to improve functionality in a similar way 
to previous work with other polysaccharides (Fissore, et. al., 2007) such as the pectic 
polymer from Glinus oppositifolius (Inngjerdingen, et. al., 2007). 
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